Diploma (LON:DPLM) Stock Crosses Above 200-Day Moving Average – Time to Sell?

Diploma PLC (LON:DPLM)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 4,276.46 ($57.85) and traded as high as GBX 4,668.32 ($63.15). Diploma shares last traded at GBX 4,638 ($62.74), with a volume of 112,410 shares changing hands.

Diploma Stock Performance

The company’s 50-day moving average price is GBX 4,142.96 and its two-hundred day moving average price is GBX 4,277.52. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The stock has a market cap of £6.19 billion, a PE ratio of 53.31, a PEG ratio of 2.82 and a beta of 0.75.

Diploma (LON:DPLM) last posted its quarterly earnings data on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) earnings per share for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. On average, equities research analysts forecast that Diploma PLC will post 163.7995512 EPS for the current year.

Insider Activity

In other Diploma news, insider Katie Bickerstaffe bought 13 shares of the firm’s stock in a transaction that occurred on Tuesday, May 20th. The shares were bought at an average price of GBX 4,982 ($67.40) per share, for a total transaction of £647.66 ($876.16). Also, insider David S. Lowden acquired 750 shares of the firm’s stock in a transaction on Friday, March 21st. The stock was purchased at an average price of GBX 3,928 ($53.14) per share, for a total transaction of £29,460 ($39,853.90). In the last quarter, insiders have purchased 1,346 shares of company stock worth $5,393,173. 0.52% of the stock is currently owned by corporate insiders.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.